论文部分内容阅读
目的:对全胸腔镜肺叶切除术在临床早期肺癌的应用价值进行分析探讨。方法:选取2012年6月~2013年6月160例在本院接受早期肺癌治疗的患者,其中,82例按照全胸腔镜肺叶切除术进行治疗的患者为VATS组,78例按照常规开胸肺叶切除术进行治疗的患者为OT组。将两组的淋巴清扫组数、手术持续时长、术中出血量、术后并发症发生率和术后疼痛评分进行比较。结果:两组患者淋巴结清扫组数、手术时间比较差异无统计学意义(P>0.05),而VATS组(P<0.05)的术中出血量、术后置管引流时间、术后住院时间、术后并发症发生率均明显少于OT组(P<0.05)。结论:全胸腔镜肺叶切除手术在临床早期肺癌的治疗中具有创口小、痛苦程度低、出血量少、术后并发症少等优点,值得在各医院推广应用。
Objective: To analyze the value of total thoracoscopic lobectomy in early clinical stage of lung cancer. Methods: A total of 160 patients undergoing early lung cancer in our hospital from June 2012 to June 2013 were enrolled. Among them, 82 patients undergoing VATS were treated with VATS and 78 patients underwent conventional thoracic lobectomy Patients undergoing resection were treated with OT. The number of lymphadenectomy group, duration of operation, intraoperative blood loss, incidence of postoperative complications and postoperative pain score were compared between the two groups. Results: There were no significant differences in the number of lymph node dissection and operation time between the two groups (P> 0.05), but the intraoperative blood loss, postoperative catheter drainage time, postoperative hospital stay, Postoperative complications were significantly less than the OT group (P <0.05). Conclusion: Thoracoscopic lobectomy has the advantages of small wound, low degree of pain, less blood loss and less postoperative complications in the treatment of early-stage lung cancer. It is worth to be popularized and applied in various hospitals.